|
|
|
|
| Discover the future of iPSC-based therapies in this free Cell & Gene Live digital event. Experts will share insights on emerging applications, regulatory challenges, gene editing advancements, and key safety considerations in scalable iPSC manufacturing. Don't miss this opportunity to hear from leaders at the forefront of regenerative medicine. Supported by Invetech. |
|
|
|
|
By Carl Accettura, Global Pharma Advisory | Data quality and exceptions handling were key discussion points during a March PDG-FDA town hall, where stakeholders shared updates on progress and unfinished work. | |
|
|
|
| New Container Protects Bulk Frozen Biopharmaceuticals | Q&A | W.L. Gore & Associates | Learn more about a flexible freeze container that maintains package integrity after freezing at -86 °C. (-123 °F) through its durable design, minimizing product loss due to package failure. |
|
|
|
|
|
|
|
In this segment of the Cell & Gene Live, Unlocking the Full Potential of AAV-Mediated Gene Delivery, David Dismuke, Ph.D., Chief Technical Officer, Forge Biologics and Nina Hunter, Ph.D., VP Corporate Strategy at REGENXBIO, the panelists discuss the overall clinical development strategy for AAV based gene therapies. |
|
|
|
|
|
| What To Look For In An Oncology CRO | Article | By Kris O’Brien, TFS HealthScience | Learn seven of the critical factors for choosing an oncology-focused CRO that enable sponsors to identify partners aligning with their clinical research objectives. |
|
|
|
|
CLINICAL TRIALS SOLUTIONS |
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|